Detection of circulating tumor in lymphoma patients using dPCR-based liquid biopsy in clinical routine, an observational study
Recruiting
- Conditions
- C71.9Brain, unspecified
- Registration Number
- DRKS00034686
- Lead Sponsor
- niversitätsklinikum Freiburg Medizinische Klinik I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
Suspected CNS-lymphoma, suspected lymphoma progression or MRD monitoring lymphoma
Exclusion Criteria
< 18 years
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reason for and implications of ctDNA analyses from lymphoma patients: Systematic evaluation of clinical data assessing the reasons for ctDNA analyses from CSF, blood plasma and vitreous fuid and their implications on patient management.
- Secondary Outcome Measures
Name Time Method Systematic evaluation of the molecular results: ctDNA detection rates, ctDNA concentrations, turnover time, and other molecular specifics related to the dPCR analyses will be evaluated.